In addition, the decreased number of CD8(+) T cells observed in the peripheral blood of cancer patients (data not shown), and the possibly decreased induction and suppressed activation of CTL, may be influenced by factors such as TGF-β and IL-10 from cancer cells, as well as by DC lipid accumulation. The gene discussed is CD8A; the disease is cancer.